Evaluation of Patient Compliance, Quality of Life Impact and Cost-Effectiveness of a "Test In-Train Out" Exercise-Based Rehabilitation Program for Patients With Intermittent Claudication
スポンサーリンク
概要
- 論文の詳細を見る
Background: Patients with intermittent claudication (IC) could benefit from low-cost, effective rehabilitative programs. This retrospective study evaluates compliance, impact on Quality of Life (QoL) and cost-effectiveness of a hospital prescribed, at-home performed (Test-in/Train-out) rehabilitative program for patients with IC. Methods and Results: Two-hundred and eighty-nine patients with IC (71±10.1 years, M=210) were enrolled for a 2-year period. Two daily 10-min home walking sessions at maximal asymptomatic speed were prescribed, with serial check-ups at the hospital. Compliance with the program was assessed by assigning a score of 1 (lowest compliance) to 4 (highest compliance). The SF-36 questionnaire and a constant-load treadmill test were used to evaluate QoL and Initial/Absolute Claudication Distance, respectively. Both direct and indirect costs of the program were considered for cost-effectiveness analysis. Two-hundred and fifty patients (70.5±9.2 years, M=191), at Fontaines II-B stage (86%), were included in the study. No adverse events were reported. The average compliance score was 3.1. At discharge, both SF-36 domains and walking performance significantly increased (P<0.0001). A total of 1,839 in-hospital check-ups (7.36 /patient) were performed. Direct and indirect costs represented 93% and 7% of the total costs, respectively. The average costs of a visit and of a therapy cycle were C68.93 and C507.20, respectively. The cost to walk an additional meter before stopping was C9.22. Conclusions: A Test-in/Train-out program provided favourable patient compliance, QoL impact and cost-effectiveness in patients with IC. (Circ J 2011; 75: 2128-2134)
論文 | ランダム
- 46.脳卒中患者のDichotic Listening Performance(言語・その他I)
- 「薬剤師のためのアンチ・ドーピングガイドブック」のポイントとその使い方 (特集 アンチ・ドーピング)
- 生産管理研究会報告
- 多種生産における原価低減の諸問題(多種少量生産管理)
- 腎細胞癌における第3染色体短腕のヘテロ接合性の消失 : 消失頻度と病理組織所見及び臨床病期との関連 : 第79回日本泌尿器科学会総会